DR. JOHN Y. TELEVANTOS

Corporate Board Profile

Tech Score: 0/100

BALCHEM CORP

Filing Date	Source Excerpt
2013-05-06	Dr. John Y. Televantos, age 60, a Class 3 director whose current term expires in 2014, has been a director since February 2005, and lead director since August of 2010. Dr. Televantos is a Partner at Arsenal Capital Partners, Inc., a private equity investment firm, where he leads the Chemicals and Materials practice of the firm.
2017-04-27	Dr. John Y. Televantos, age 64, a Class 3 director whose current term expires in 2017, has been a director since February 2005, and lead director since August 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer, McMillan and Wineinger. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. ... The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company’s directors (other than Mr. Harris, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2016. ... John Televantos $79,000 fees earned or paid in cash, $110,017 stock awards, total $189,017.

Filing Date

Source Excerpt

2013-05-06

Dr. John Y. Televantos, age 60, a Class 3 director whose current term expires in 2014, has been a director since February 2005, and lead director since August of 2010. Dr. Televantos is a Partner at Arsenal Capital Partners, Inc., a private equity investment firm, where he leads the Chemicals and Materials practice of the firm.

2017-04-27

Dr. John Y. Televantos, age 64, a Class 3 director whose current term expires in 2017, has been a director since February 2005, and lead director since August 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer, McMillan and Wineinger. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. ... The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company’s directors (other than Mr. Harris, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2016. ... John Televantos $79,000 fees earned or paid in cash, $110,017 stock awards, total $189,017.

Data sourced from SEC filings. Last updated: 2025-07-01